Day: January 8, 2024
Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) — Citeline, a Norstella company providing robust data and expert business intelligence to the pharmaceutical industry, will offer exclusive access to insights from the 42nd Annual J.P. Morgan Healthcare Conference (JPM) Jan. 8–11, 2024 in San Francisco. JPM, the industry’s largest healthcare investment symposium, provides a detailed look […]
Under the Theme ‘A Matter of Time’: The Sixth edition of the Summit, organized by the Department of Culture and Tourism – Abu Dhabi, will take place at Manarat Al Saadiyat from 3 to 5 March 2024
Fiammetta Rocco, Dr. Rafal Niemojewski, Maya Allison, Sultan Sooud Al Qassemi, Manal Ataya. Culture Summit 2022. Courtesy DCT Abu Dhabi The Summit will bring together leaders from fields of art, heritage, media, museums, music, public policy and technology from over 90 countries to explore our changing relation to time Organised with leading global partners including […]
Ambarella Brings Generative AI Capabilities to Edge Devices; Introduces N1 System-on-Chip Series for On-Premise Applications
Single SoC Supports One to 34 Billion-Parameter, Multi-Modal LLMs With Low Power Consumption, Enabling Generative AI for Edge Endpoint Devices Ambarella’s New N1 SoC Supports Up to 34 Billion-Parameter, Multi-Modal Large Language Models With Low Power Consumption, Enabling Generative AI for Edge Endpoint Devices Ambarella is demonstrating multi-modal LLMs running on its new N1 SoC […]
Nasdaq European Markets sustains its strong position in the SME listings and sustainable debt market in 2023
Nasdaq European Markets welcomed 33 listings, including 7 initial public offerings (IPOs), raising a total of EUR 431 million risk capital and EUR 11.6 bn in secondary offerings Nasdaq celebrated its 130th company to transfer from Nasdaq First North Growth Market to Main Market STOCKHOLM, Sweden, Jan. 08, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) […]
Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva
Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva Colobreathe® is an inhaled antibiotic for the management of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients The acquisition will help ensure continued access to an important medicine for this vulnerable patient population First rare disease medicine to be added to the Essential Pharma product […]
(EDITORIAL from Korea Herald on Jan. 8)
Instigation of conflict within the South has always been the North’s key strategy
South Korea’s Joint Chiefs of Staff said North Korea fired some 200 artillery shells into waters near the western sea border on Friday morning, prompting the South to …
Seoul city weighs increasing subway base fare by 150 won in July
SEOUL, The Seoul city government said Monday it is considering increasing the base fare for a subway ride in Seoul by 150 won (US$0.11) in July, city officials said.
The fare hike will likely take place in line with the official launch of the all-in…
(LEAD) FM nominee vows to accelerate S. Korea-U.S.-Japan cooperation amid growing N.K. threats
SEOUL, South Korea’s foreign minister nominee vowed Monday to focus on accelerating cooperation with the United States and Japan amid growing missile and nuclear threats from North Korea.
North Korea has recently upped the ante on the Korean Peninsu…
Celltrion to cancel about 1 pct of outstanding shares
SEOUL, Celltrion Inc., a South Korean pharmaceutical company, said Monday it has begun the process of cancelling about 1 percent of its outstanding shares worth some 500 billion won (US$379.8 million) to boost shareholder value.
The value of shares …
S. Korean military reaffirms N. Korea’s Jan. 6 firing drills
SEOUL, The South Korean military on Monday reaffirmed that North Korea conducted live-fire drills from its western coast Saturday, denying Pyongyang’s claims it detonated explosives as “a deceptive operation.”
The Joint Chiefs of Staff (JCS) said No…